Eli Lilly Zepbound Results - Search News

Order byBest matchMost fresh

News

Eli Lilly, Zepbound

Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy

The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs.

Continue reading

· 3d · on MSN

· 3d · on MSN

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly’s Zepbound shows superiority in head-to-head weight loss study

Hosted on MSN3d

Eli Lilly's Zepbound Outperforms Wegovy In New Obesity Trial, But Trump's Drug Pricing Plan Keeps Retail Traders Wary

Eli Lilly and Co's obesity drug Zepbound led to greater weight loss than Novo Nordisk's Wegovy in a head-to-head Phase ...

Zepbound vs. Wegovy: Here's which weight loss drug worked best in first trial

People taking Zepbound, Eli Lilly’s obesity drug, lost almost 50% more weight than individuals using Novo Nordisk’s ...

Los Angeles Daily News3d

Zepbound trims more belly fat than Wegovy, study shows

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results